Unlocking the mysteries of the human brain

The Sydney Brain Bank is helping researchers uncover the causes of neurodegenerative disease and build a future with better diagnosis, treatment and prevention.

Unlocking the mysteries of the human brain

July 1, 2026
The Sydney Brain Bank is helping researchers uncover the causes of neurodegenerative disease and build a future with better diagnosis, treatment and prevention.
Read Transcript

The challenge

Neurodegenerative diseases such as Alzheimer's Disease, Parkinson's Disease and Motor Neurone Disease have a significant and growing impact in Australia. Dementia is now the leading cause of death in Australia and affects more than 400,000 people. With an ageing population, this number is expected to increase to more than 1 million by 2065, placing increasing pressure on the healthcare system, aged care services and families.1

While these conditions are influenced by a complex interplay of genetic, lifestyle and environmental factors, many questions remain about how environmental exposures affect brain health and contribute to disease.

Research has linked factors such as repetitive head injury, air pollution and other environmental toxins to changes in brain health. However, much remains unknown about the role these exposures may play in neurodegenerative disease.

The Sydney Brain Bank (SBB) at Neuroscience Research Australia (NeuRA) addresses the critical need for post-mortem brain and spinal cord tissue to advance scientific understanding of healthy ageing and neurodegenerative conditions, as well as the impact of environmental toxins on brain health and disease.

Highlights

In 2025, NeuRA researchers published a world-first study identifying per- and polyfluoroalkyl substances (PFAS), often referred to as "forever chemicals", in brain tissue collected through the SBB. The findings demonstrated that these environmental chemicals can cross the blood-brain barrier and accumulate in human brain tissue. The work attracted significant national attention and provided essential groundwork for future research into whether PFAS and other environmental toxins preferentially accumulate in diseases such as Motor Neurone Disease and Parkinson's Disease, both of which are thought to be impacted by environmental toxins.

The role of philanthropy

Hearts & Minds funding, as nominated by Caledonia, has been critical in sustaining the infrastructure of the SBB. This funding has helped the facility fulfil its mission of collecting, characterising, storing, and distributing high-quality human brain and spinal cord tissue for research, ensuring scientists have access to the resources needed to advance discoveries.

What this could unlock

The SBB is creating new opportunities to better understand the causes of neurodegenerative disease and the factors that influence brain health. Through this work, researchers hope to support earlier diagnosis, improved treatments and better outcomes for people affected by these devastating conditions.

1. Dementia Australia, Dementia facts and figures.

This project is supported by Hearts & Minds, as nominated by Core Fund Manager, Caledonia. For further information and updates, visit NeuRA. This content was last updated in July 2026.

The challenge

Neurodegenerative diseases such as Alzheimer's Disease, Parkinson's Disease and Motor Neurone Disease have a significant and growing impact in Australia. Dementia is now the leading cause of death in Australia and affects more than 400,000 people. With an ageing population, this number is expected to increase to more than 1 million by 2065, placing increasing pressure on the healthcare system, aged care services and families.1

While these conditions are influenced by a complex interplay of genetic, lifestyle and environmental factors, many questions remain about how environmental exposures affect brain health and contribute to disease.

Research has linked factors such as repetitive head injury, air pollution and other environmental toxins to changes in brain health. However, much remains unknown about the role these exposures may play in neurodegenerative disease.

The Sydney Brain Bank (SBB) at Neuroscience Research Australia (NeuRA) addresses the critical need for post-mortem brain and spinal cord tissue to advance scientific understanding of healthy ageing and neurodegenerative conditions, as well as the impact of environmental toxins on brain health and disease.

Highlights

In 2025, NeuRA researchers published a world-first study identifying per- and polyfluoroalkyl substances (PFAS), often referred to as "forever chemicals", in brain tissue collected through the SBB. The findings demonstrated that these environmental chemicals can cross the blood-brain barrier and accumulate in human brain tissue. The work attracted significant national attention and provided essential groundwork for future research into whether PFAS and other environmental toxins preferentially accumulate in diseases such as Motor Neurone Disease and Parkinson's Disease, both of which are thought to be impacted by environmental toxins.

The role of philanthropy

Hearts & Minds funding, as nominated by Caledonia, has been critical in sustaining the infrastructure of the SBB. This funding has helped the facility fulfil its mission of collecting, characterising, storing, and distributing high-quality human brain and spinal cord tissue for research, ensuring scientists have access to the resources needed to advance discoveries.

What this could unlock

The SBB is creating new opportunities to better understand the causes of neurodegenerative disease and the factors that influence brain health. Through this work, researchers hope to support earlier diagnosis, improved treatments and better outcomes for people affected by these devastating conditions.

1. Dementia Australia, Dementia facts and figures.

This project is supported by Hearts & Minds, as nominated by Core Fund Manager, Caledonia. For further information and updates, visit NeuRA. This content was last updated in July 2026.

Disclaimer: This material has been prepared by Hearts & Minds, published on July 1, 2026. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
February 14, 2023

Bringing Equity and Diversity to Genomic Medicine

Professor Daniel MacArthur, Director of the Centre for Population Genomics has big goals to bring equity and diversity into genomic medicine in Australia, something surprisingly inadequate presently.

Read More
September 6, 2022

VCCRI: 'Heart in a Box'

An Australian method of preserving donated hearts has boosted the number of successful transplants across the world, with new research demonstrating similar survival rates to traditional transplants.

Read More
February 24, 2022

Impact Video: Cerebral Palsy Alliance

This video features Professor Nadia Badawi AM, Professor Alistair McEwan, Paul Rayson and others discussing the incredible impact our partnership will have.

Read More
February 24, 2022

New Partnership with Cerebral Palsy Alliance

We’re excited to announce a new partnership with the Cerebral Palsy Alliance and are proud to be supporting this important research.

Read More
August 3, 2021

Australian breakthrough to stop heart arteries from clogging

Victor Chang scientist has led landmark research that has the potential to stop arteries of the heart from becoming clogged by targeting a particular gene.

Read More
October 12, 2020

Beneficiary Profile: Victor Chang

Cardiovascular disease is the number one cause of death globally and costs the Australian economy $12 billion each year. Every 12 minutes, one Australian dies from the disease. This is why the Victor Chang Cardiac Research Institute is dedicated to finding cures through their world class research.

Read More
September 23, 2020

Silent wave' of brain damage could follow pandemic

Australia urgently needs to prepare for a "silent wave" of COVID-19, which appears to be taking the form of long-term neurological side effects following infection with the virus.

Read More
September 8, 2020

Beneficiary Profile: Black Dog Institute

1 in 5 of us will experience symptoms of mental illness in any given year. In Australia that’s around 5 million people. And roughly 60% of these people won’t seek help. Learn what Black Dog is doing to create a mentally healthier world for everyone.

Read More
August 10, 2020

Beneficiary Profile: RPA Green Light

Emergency departments are the frontline of health care, with one in seven Australians seeking help from a hospital emergency department every year. Our medical staff depend on research findings to help inform their responses to urgent patient needs.

Read More
July 7, 2020

Beneficiary Profile: The Florey

Every year, 4.7 million Australians are diagnosed with one of the conditions that the Florey study. That's why they believe everyone has a stake in medical research.

Read More
June 9, 2020

Beneficiary Profile: Orygen

1 in 5 young people will have experienced a depressive episode by the time they are 18. With thanks to Cooper Investors and Hearts & Minds, we have been able to put youth mental health on the global agenda and progress our work in developing a global mental health framework.

Read More
November 22, 2019

Impact Video Series: Sydney Children's Hospital Foundation

We interviewed leading individuals from our beneficiaries to discuss the importance of medical research, their recent breakthroughs and the vital need for private funding.

Read More
May 29, 2019

Winning Hearts and Minds

Mark Nelson of Caledonia discusses his connection with the Florey Institute, one of our beneficiaries, and why he's involved with Hearts and Minds.

Read More